MYBL2 and breast carcinoma: If overexpression of MYBL2, as well as A3B, is associated with breast cancer progression, polymorphisms in the expression quantitative trait loci (eQTL) that are associated with MYBL2 mRNA expression would be expected to be significantly associated with disease outcome.